NASDAQ:TSVT - Nasdaq - US9013841070 - Common Stock - Currency: USD
Taking everything into account, TSVT scores 3 out of 10 in our fundamental rating. TSVT was compared to 567 industry peers in the Biotechnology industry. While TSVT seems to be doing ok healthwise, there are quite some concerns on its profitability. TSVT is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -11.94% | ||
ROE | -27.16% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 52.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -1.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.67 | ||
Quick Ratio | 4.67 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
5
+0.02 (+0.4%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 7.03 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.26 | ||
P/tB | 1.3 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -11.94% | ||
ROE | -27.16% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 52.43% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 9.96% | ||
Cap/Sales | 1.87% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.67 | ||
Quick Ratio | 4.67 | ||
Altman-Z | -1.3 |